WhitTier Trust Company’s Ionis Pharmaceuticals IONS Stock Holding History

WhitTier Trust Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-157	Closed	-$5.48K	–	1445
2024 Q4	$5.48K	Hold	157	–	–	﹤0.01%	1133
2024 Q3	$6.29K	Sell	157 -61	-28%	-$2.84K	﹤0.01%	1094
2024 Q2	$10.4K	Sell	218 -123	-36%	-$5.04K	﹤0.01%	988
2024 Q1	$14.8K	Hold	341	–	–	﹤0.01%	901
2023 Q4	$17.2K	Hold	341	–	–	﹤0.01%	866
2023 Q3	$15.5K	Hold	341	–	–	﹤0.01%	862
2023 Q2	$14K	Sell	341 -593	-63%	-$22.8K	﹤0.01%	926
2023 Q1	$33.4K	Buy	934 +593	+174%	+$22.3K	﹤0.01%	754
2022 Q4	$12.9K	Hold	341	–	–	﹤0.01%	909
2022 Q3	$15K	Sell	341 -64	-16%	-$2.7K	﹤0.01%	854
2022 Q2	$15K	Hold	405	–	–	﹤0.01%	857
2022 Q1	$15K	Hold	405	–	–	﹤0.01%	855
2021 Q4	$12K	Buy	405 +246	+155%	+$7.74K	﹤0.01%	879
2021 Q3	$5K	Buy	+159	New	+$5.99K	﹤0.01%	1003

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

WhitTier Trust Company's IONS Position: Q1 2025 in Review

WhitTier Trust Company sold out of Ionis Pharmaceuticals (IONS) in Q1 2025, closing a stake of 157 shares — an estimated $5.48K sold.

WhitTier Trust Company first reported a position in IONS in Q3 2021 and held it in 14 quarters. The position peaked at $33.4K in Q1 2023. 343 funds tracked by Wall St. Rank hold IONS as of Q1 2025.

WhitTier Trust Company reported no remaining Ionis Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
WhitTier Trust Company sold 157 Ionis Pharmaceuticals shares in Q1 2025, an estimated $5.48K.
WhitTier Trust Company first reported a position in Ionis Pharmaceuticals in Q3 2021 and held it in 14 quarters.
WhitTier Trust Company's Ionis Pharmaceuticals position peaked at $33.4K in Q1 2023.
343 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2025.

Based on WhitTier Trust Company's 13F filing for Q1 2025, filed 2 May 2025.